MAIA Biotechnology, Inc. (NYSE:MAIA), a clinical-stage biopharmaceutical company, has announced a private placement agreement ...

Biogen Inc. (NASDAQ: BIIB )’s recent partnership with City Therapeutics, Inc. to develop RNAi therapies for central nervous ...

Dr. David Feifel, Kadima’s founder and a recognized leader in interventional psychiatry, will join HOPE Therapeutics as Chief ...